Suppr超能文献

抑制素和激活素可通过免疫组织化学在卵巢肿瘤组织中检测到。

Inhibin and activin are demonstrable by immunohistochemistry in ovarian tumor tissue.

作者信息

Gurusinghe C J, Healy D L, Jobling T, Mamers P, Burger H G

机构信息

Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia.

出版信息

Gynecol Oncol. 1995 Apr;57(1):27-32. doi: 10.1006/gyno.1995.1096.

Abstract

Elevated serum immunoreactive inhibin concentrations have been reported in patients with mucinous and granulosa cell tumors of the ovary. The present study aimed to determine whether the inhibins and/or the related peptides, the activins, were demonstrable within ovarian tumor tissue. Immunohistochemical analyses were performed on 11 ovarian tumors, 5 mucinous, 3 serous, 1 granulosa, 1 clear cell, and 1 metastatic colonic cancer. Both monoclonal and polyclonal antisera specific for inhibin-A, activin-A, and activin-B, and their alpha-, beta A- and beta B-subunits were used. The mucinous cells of all five mucinous tumors showed positive staining for activin-A and activin-B, and their beta A- and beta B-subunits, and three stained positive for inhibin-A and the alpha-subunit. The granulosa cell tumor also showed positive staining for inhibin-A and the activins. The remaining tumors were negative. The findings are consistent with the hypersecretion of inhibin (and possibly activin) by some ovarian malignancies and suggest that immunohistochemistry for the inhibins and the activins should be explored further in the classification of ovarian malignancies.

摘要

据报道,卵巢黏液性肿瘤和颗粒细胞瘤患者血清免疫反应性抑制素浓度升高。本研究旨在确定抑制素和/或相关肽——激活素是否在卵巢肿瘤组织中可被检测到。对11例卵巢肿瘤进行了免疫组织化学分析,其中5例黏液性肿瘤、3例浆液性肿瘤、1例颗粒细胞瘤、1例透明细胞癌和1例转移性结肠癌。使用了针对抑制素-A、激活素-A和激活素-B及其α、βA和βB亚基的单克隆和多克隆抗血清。所有5例黏液性肿瘤的黏液细胞均显示激活素-A、激活素-B及其βA和βB亚基呈阳性染色,3例抑制素-A和α亚基呈阳性染色。颗粒细胞瘤也显示抑制素-A和激活素呈阳性染色。其余肿瘤均为阴性。这些发现与某些卵巢恶性肿瘤中抑制素(可能还有激活素)的过度分泌一致,并表明在卵巢恶性肿瘤的分类中应进一步探索抑制素和激活素的免疫组织化学。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验